Hearts from rodents exposed to intermittent hypoxia or erythropoietin are protected against ischemia-reperfusion injury

Circulation

Volumn 108, Issue 1, 2003, Pages 79-85

  Cai, Zheqing ^a   Manalo, Dominador J ^a   Wei, Guo ^a   Rodriguez, E Rene ^a   Fox Talbot, Karen ^a   Lu, Huasheng ^b   Zweier, Jay L ^a   Semenza, Gregg L ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CMSC 1004 ^*

Author keywords

Hypoxia; Ischemia; Myocardial infarction

Indexed keywords

ERYTHROPOIETIN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MESSENGER RNA; RECOMBINANT ERYTHROPOIETIN;

ALLELE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CONVALESCENCE; DRUG EFFECT; EXPOSURE; GENE LOCUS; GENETIC CODE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HETEROZYGOTE; HYPOXIA; ISOLATED HEART; KNOCKOUT MOUSE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN INDUCTION; RAT; REPERFUSION INJURY; TREATMENT OUTCOME; WILD TYPE;

ANIMALS; ANOXIA; ERYTHROPOIETIN; GENE EXPRESSION; HEART; HETEROZYGOTE; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; ISCHEMIC PRECONDITIONING, MYOCARDIAL; KIDNEY; MALE; MICE; MICE, MUTANT STRAINS; MYOCARDIUM; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ERYTHROPOIETIN; REPERFUSION INJURY; RNA, MESSENGER; TIME FACTORS; TRANSCRIPTION FACTORS;

EID: 0038163900     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000078635.89229.8A     Document Type: Article

References (28)

1. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation. 1986; 74:1124-1136.
2. Williams RS, Benjamin IJ. Protective responses in the ischemic myocardium. J Clin Invest. 2000;106:813-818.
3. Yellon DM, Dana A. The preconditioning phenomenon: a tool for the scientist or a clinical reality? Circ Res. 2000;87:543-550.
4. Bolli R. The late phase of preconditioning. Circ Res. 2000;87:972-983.
5. Ostadalova I, Ostadal B, Jarkovska D, et al. Ischemic preconditioning in chronically hypoxic neonatal rat heart. Pediatr Res. 2002;52:561-567.
6. Rafiee P, Shi Y, Kong X, et al. Activation of protein kinases in chronically hypoxic infant human and rabbit hearts: role in cardioprotection. Circulation. 2002;106:239-245.
7. Tajima M, Katayose D, Bessho M, et al. Acute ischemic preconditioning and chronic hypoxia independently increase myocardial tolerance to ischemia. Cardiovasc Res. 1994;28:312-319.
8. Semenza GL. Signal transduction to hypoxia-inducible factor 1. Biochem Pharmacol. 2002;64:993-998.
9. 2 tension. Proc Natl Acad Sci USA. 1995;92:5510-5514.
10. Stroka DM, Burkhardt T, Desbaillets I, et al. HIF-1 is expressed in normoxic tissue and displays an organ-specific regulation under systemic hypoxia. FASEB J. 2001;15:2445-2453.
11. 2 homeostasis by hypoxia-inducible factor 1α. Genes Dev. 1998;12: 149-162.
12. Wang P, Chen H, Qin H, et al. Overexpression of human copper, zinc-superoxide dismutase (SODI) prevents postischemic injury. Proc Natl Acad Sci U S A. 1998;95:4556-4560.
13. Kline DD, Peng YJ, Manalo DJ, et al. Defective carotid body function and impaired ventilatory responses to chronic hypoxia in mice partially deficient for hypoxia-inducible factor 1α. Proc Natl Acad Sci USA. 2002;99:821-826.
14. Shimoda LA, Manalo DJ, Sham JS, et al. Partial HIF-1α deficiency impairs pulmonary arterial myocyte electrophysiological responses to hypoxia. Am J Physiol. 2001;281:L202-L208.
15. Yu AY, Shimoda LA, Iyer NV, et al. Impaired physiological responses to chronic hypoxia in mice partially deficient for hypoxia-inducible factor 1α. J Clin Invest. 1999;103:691-696.
16. Semenza GL, Wang GL. A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol Cell Biol. 1992;12: 5447-5454.
17. Koury MJ, Bondurant MC. Erythropoietin retards DNA breakdown and prevents programmed death in erythroid progenitor cells. Science. 1990; 248:378-381.
18. Siren AL, Fratelli M, Brines M, et al. Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress. Proc Natl Acad Sci U S A. 2001;98:4044-4049.
19. Digicaylioglu M, Lipton SA. Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-κB signalling cascades. Nature. 2001;412:641-647.
20. Chong ZZ, Kang JQ, Maiese K. Erythropoietin is a novel vascular protectant through activation of Akt1 and mitochondrial modulation of cysteine proteases. Circ Res. 2002;106:2973-2979.
21. Xi L, Tekin D, Gursoy E, et al. Evidence that NOS2 acts as a trigger and mediator of late preconditioning induced by acute systemic hypoxia. Am J Physiol. 2002;283:H5-H12.
22. Scarabelli T, Stephanou A, Rayment N, et al. Apoptosis of endothelial cells precedes myocyte cell apoptosis in ischemia/reperfusion injury. Circulation. 2001;104:253-256.
23. Bergeron M, Gidday JM, Yu AY, et al. Role of hypoxia-inducible factor 1 in hypoxia-induced ischemic tolerance in neonatal rat brain. Ann Neurol. 2000;48:285-296.
24. Digicaylioglu M, Bichet S, Marti HH, et al. Localization of specific erythropoietin binding sites in defined areas of the mouse brain. Proc Natl Acad Sci USA. 1995;92:3717-3720.
25. Morishita E, Masuda S, Nagao M, et al. Erythropoietin receptor is expressed in rat hippocampal and cerebral cortical neurons, and erythropoietin prevents in vitro glutamate-induced neuronal death. Neuroscience. 1997;76:105-116.
26. Anagnostou A, Liu Z, Steiner M, et al. Erythropoietin receptor mRNA expression in human endothelial cells. Proc Natl Acad Sci U S A. 1994; 91:3974-3978.
27. Yu X, Shacka JJ, Eells JB, et al. Erythropoietin receptor signalling is required for normal brain development. Development. 2002;129: 505-516.
28. Juul SE, Yachnis AT, Christensen RD. Tissue distribution of erythropoietin and erythropoietin receptor in the developing human fetus. Early Hum Dev. 1998;52:235-249.